1. Home
  2. YMAB vs EP Comparison

YMAB vs EP Comparison

Compare YMAB & EP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • YMAB
  • EP
  • Stock Information
  • Founded
  • YMAB 2015
  • EP 1983
  • Country
  • YMAB United States
  • EP United States
  • Employees
  • YMAB N/A
  • EP N/A
  • Industry
  • YMAB Biotechnology: Pharmaceutical Preparations
  • EP Oil & Gas Production
  • Sector
  • YMAB Health Care
  • EP Energy
  • Exchange
  • YMAB Nasdaq
  • EP Nasdaq
  • Market Cap
  • YMAB 218.4M
  • EP 162.1M
  • IPO Year
  • YMAB 2018
  • EP N/A
  • Fundamental
  • Price
  • YMAB $4.06
  • EP $4.17
  • Analyst Decision
  • YMAB Buy
  • EP
  • Analyst Count
  • YMAB 11
  • EP 0
  • Target Price
  • YMAB $18.73
  • EP N/A
  • AVG Volume (30 Days)
  • YMAB 220.0K
  • EP 27.3K
  • Earning Date
  • YMAB 05-13-2025
  • EP 05-23-2025
  • Dividend Yield
  • YMAB N/A
  • EP N/A
  • EPS Growth
  • YMAB N/A
  • EP N/A
  • EPS
  • YMAB N/A
  • EP N/A
  • Revenue
  • YMAB $87,685,000.00
  • EP $44,039,178.00
  • Revenue This Year
  • YMAB N/A
  • EP N/A
  • Revenue Next Year
  • YMAB $18.83
  • EP N/A
  • P/E Ratio
  • YMAB N/A
  • EP N/A
  • Revenue Growth
  • YMAB 3.38
  • EP 9.71
  • 52 Week Low
  • YMAB $3.84
  • EP $3.76
  • 52 Week High
  • YMAB $17.47
  • EP $8.46
  • Technical
  • Relative Strength Index (RSI)
  • YMAB 44.30
  • EP 39.43
  • Support Level
  • YMAB $3.76
  • EP $3.89
  • Resistance Level
  • YMAB $4.26
  • EP $4.88
  • Average True Range (ATR)
  • YMAB 0.28
  • EP 0.33
  • MACD
  • YMAB -0.00
  • EP -0.04
  • Stochastic Oscillator
  • YMAB 35.71
  • EP 25.95

About YMAB Y-mAbs Therapeutics Inc.

Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company. It is mainly engaged in the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. DANYELZA, is the first FDA-approved product of the company which is a recombinant humanized immunoglobulin G, subtype 1k, or IgG1k, monoclonal antibody or mAb that targets ganglioside GD2, which is expressed in various neuroectoderm-derived tumors and sarcomas.

About EP Empire Petroleum Corporation

Empire Petroleum Corp is a conventional oil and natural gas producer with a main focus in the US onshore. The company possesses long-life, mature, producing assets with slow decline profiles in the Permian Basin, Bakken region and central Gulf Coast region, in the states of New Mexico, North Dakota, Montana, Louisiana and Texas. It has production from operated and non-operated wells in Lea County in New Mexico, Bottineau, Renville, Burke, and McKenzie Counties in North Dakota, Richland County in Montana, St. Landry, Beauregard Parishes in Louisiana and Houston, Leon and Madison Counties in Texas.

Share on Social Networks: